Skip to main content
. 2019 Mar 12;22:101770. doi: 10.1016/j.nicl.2019.101770

Table 1.

Demographic and clinical data.

bvFTD (n = 15) Controls (n = 19) T (χ2) p
Age (SD) 67.3 (6.65) 66.6 (6.45) −0.286 0.784
Sex (M/F) 9/6 10/9 (0.185) 0.667
Symptom onset (SD) 2.1 (1.04)
MMSE (/30) 26.4 (1.60) 29.3 (0.59) 6.75a <0.001*
RAVLT# A1-A5 (/75) 30.6 (9.22) 50.8 (7.73) 6.63 <0.001*
% recall 60.8 (33.65) 80.1 (18.11) 1.89a 0.078
Reco (/15) 12.3 (3.38) 14.1 (1.35) 1.77a 0.098
BNT (/60) 39.3 (11.72) 54.7 (2.49) 4.99a <0.001*
AVFμ 15.4 (6.01) 22.6 (5.91) 3.25 0.003*
TMT A (s)μ 69.7 (52.26) 33.1 (9.74) −2.40a 0.034*
B (s)£ 186.8 (149.55) 84.9 (36.72) −2.22a 0.049*
RCPMT (/24)§ 16.9 (4.30) 20.7 (2.85) 3.02 0.005*
AAT (/120) Compreh 96.0 (10.90) 109.3 (5.47) 4.40 <0.001*

SD = standard deviation, M/F = ratio males/females; MMSE = Mini Mental State Examination; RAVLT = Rey's Auditory Verbal Learning test; Reco = recognition; BNT = Boston Naming Test; AVF = Animal Verbal Fluency; TMT = Trail Making Test; RCPMT = Raven's Colored Progressive Matrices Test; AAT = Aachen Aphasia Test; Compreh = comprehension; a = Equal variances not assumed; # = N(bvFTD) = 13; μ = N(bvFTD) = 12; £ = N(bvFTD) = 11; § = N(bvFTD) = 14); * = significant group difference (p < .05).